Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
GLAXOSMITHKLINE NZ LIMITED,Recombinant Zoster Vaccine,People over 65 years of age who require a Shingrix catch-up at least 5 years post Zostavax,Recombinant Zoster Vaccine (SHINGRIX),Options for investment,Community and Hospital,National Immunisation Schedule
